Диссертация (1144820), страница 62
Текст из файла (страница 62)
– 2003. – V. 60. – P. 97–101.320.Papp F., Friedman A.L., Bereczki C., Haszon I., Kiss E., Endreffy E., TuriS. Renin-angiotensin gene polymorphism in children with uremia and essentialhypertension // Pediatr. Nephrol. – 2003. – V. 18(2). – P. 150–154.321.PappaK.I., RoubelakisM., VlachosG., MarinopoulosS., ZissouA., Anagnou N.P., Antsaklis A. Variable effects of maternal and paternal-fetalcontributiontotheriskfor preeclampsia combiningGSTP1,eNOS,and LPL gene polymorphisms // J. Matern. Fetal. Neonatal. Med.
– 2011. V. 24, №4. – P. 628–635.322.Patnala R., Clements J., Batra J. Candidate gene association studies: acomprehensive guide to useful in silico tools // BMC Genet. – 2013. – V. 14. –P.39.323.Pearson T.A., Manolio T.A. How to interpret a genome-wide associationstudy // JAMA. – 2008.
– V. 299. – P. 335–344.324.Pereira A.C., Mota G.F., Cunha R.S., Herbenhoff F.L., Mill J.G., KriegerJ.E. Angiotensinogen 235T allele "dosage" is associated with blood pressurephenotypes // Hypertension. – 2003. – V. 41(1). – P. 25–30.325.Peterson H., Laivuori H., Kerkelä E., Jiao H., Hiltunen L., Heino S., TialaI., Knuutila S., Rasi V., Kere J., Kivinen K. ROCK2 allelic variants are notassociated with pre-eclampsia susceptibility in the Finnish population // Mol. Hum.Reprod. – 2009. – V.
15. – P. 443–449.326.Phillips P.C. Epistasis--the essential role of gene interactions in thestructure and evolution of genetic systems // Nat. Rev. Genet. – 2008. – V. 9, №11. – P. 855-867.327.Pineles B.L., Romero R., Montenegro D., Tarca A.L., Han Y.M., KimY.M., Draghici S., Espinoza J., Kusanovic J.P., Mittal P., Hassan S.S., Kim C.J.401402Distinct subsets of microRNAs are expressed differentially in the human placentasof patients with preeclampsia // Am. J.
Obstet. Gynecol. – 2007. – V. 196(3). – P.261.e1-6.328.Plummer S., Tower C., Alonso P., Morgan L., Baker P., Broughton-PipkinF., Kalsheker N. Haplotypes of the angiotensin II receptor genes AGTR1 andAGTR2 in women with normotensive pregnancy and women with preeclampsia //Hum. Mutat.
– 2004. – V. 24, №1. – P. 14–20.329.Podkolodnaya O.A., Yarkova E.E., Demenkov P.S., Konovalova O.S.,.Ivanisenko V.A, Kolchanov N.A. Application of the ANDCell Computer Systemto Reconstruction and Analysis of Associative Networks Describing PotentialRelationships between Myopia and Glaucoma // Russian Journal of Genetics(Genetika).
– 2011. – V. 1, №. 1. – P. 21–28.330.Poort S.R., Rosendaal F.R., Reitsma P.H., Bertina R.M. A commongenetic variation in the 3'-untranslated region of the prothrombin gene is associatedwith elevated plasma prothrombin levels and an increase in venous thrombosis //Blood. – 1996. – Vol. 88, № 10. – P. 3698–3703.331.Popov V., Fomicheva E., Kovalev J., Schwartz E. Absence of associationbetween the angiotensin-converting enzyme gene polymorphism and borderlinehypertension in men of St Petersburg, Russia // J. Hum.
Hypertens. – 1996. – V.10(8). – P. 557–559.332.Procopciuc L., Popescu T., Jebeleanu G., Pop D., Zdrenghea D. Essentialarterial hypertension and polymorphism of angiotensinogen M235T gene // J. Cell.Mol. Med. – 2002. – V. 6(2). – P. 245–250.333.Purcell S., Neale B., Todd-Brown K., Thomas L., Ferreira M.A.R., BenderD., Maller J., Sklar P., de Bakker P.I.W., Daly M.J., Sham P.C. PLINK: a toolsetfor whole-genome association and population-based linkage analysis // AmericanJournal of Human Genetics. – 2007.
– V. 81(3). – P. 559–575.334.Puzyrev V.P., Freidin M.B. Genetic view on the phenomenon of combineddiseases in man // Acta Naturae. – 2009. – V. 1(3). – P. 52–57.402403335.Puzyrev V., Makeeva E. & Freidin M. Syntropy, genetic testing andpersonalized medicine // Personalized Medicine. – 2010. – V. 7(4). – P. 399–405.336.Qi J.H., Ebrahem Q., Moore N., Murphy G., Claesson-Welsh L., Bond M.,Baker A., Anand-Apte B.
A novel function for tissueinhibitor ofmetalloproteinases-3 (TIMP3): inhibition of angiogenesis by blockage of VEGFbinding to VEGF receptor-2 // Nat. Med. – 2003. – V. 9. – P.407–415.337.Radomski M.W., Moncada S. Regulation of vascular homeostasis by nitricoxide // Thromb. Haemost. – 1997. – V. 70. – P.
36–41.338.Radomski M.W., Moncada S. Regulation of vascular homeostasis by nitricoxide // Thromb. Haemost. – 1997. – V. 70. – P. 36–41.339.Renthal N. E., Chen C.-C., Williams K. C., Gerard R. D., Prange-Kiel J.,Mendelson C. R. MIR-200 family and targets, ZEB1 and ZEB2, modulate uterinequiescence and contractility during pregnancy and labor // PNAS. – 2010. – V.107, № 48.
– P. 20828–20833.340.Riggs E.R., Ledbetter D.H., Martin C.L. Genomic Variation: LessonsLearned from Whole-Genome CNV Analysis // Curr. Genet. Med. Rep. – 2014. –V. 2. – P. 146–150.341.Ritchie M.D., Hahn L.W.,Roodi N.,Bailey L.R.,Dupont W.D.,ParlF.F.,MooreJ.H.Multifactor-dimensionalityreductionrevealshigh-orderinteractions among estrogen-metabolism genesin sporadic breast cancer // Am. JHum. Genet. – 2001.- V. 69(1). – P. 138-147.342.Robasky K., Lewis N.E., Church G.M. The role of replicates for errormitigation in next-generation sequencing // Nat.
Rev. Genet. – 2014. – V. 15. – P.56–62.343.Rober M., J. Walter, E. Vlakh, F. Stahl, C. Kasper, T. Tennikova. New 3-Dmicroarray platform based on macroporous polymer monoliths // Anal. ChimicaActa. – 2009. – V. 644. – P. 95–103.344.RobinsonM.D., McCarthyD.J., SmythG.K.edgeR:a Bioconductor package for differential expression analysis of digital geneexpression data // Bioinformatics.
– 2010. – V. 26, №1. – P. 139–140.403404345.Rossi G.P., Cesari M., Zanchetta M., Colonna S., Maiolino G., Pedon L.,Cavallin M., Maiolino P., Pessina A.C. The T-786C endothelial nitric oxidesynthase genotype is a novel risk factor for coronary artery disease in Caucasianpatients of the GENICA study // J. Am. Coll. Cardiol. – 2003. – V. 41, № 6.
– P.930–937.346.Rupert J.L., Kidd K.K., Norman L.E., Monsalve M.V., Hochachka P.W.,Devine D.V. Genetic polymorphisms in the Renin-Angiotensin system in highaltitude and low-altitude Native American populations // Ann. Hum. Genet. –2003. – V. 67(Pt 1). – P. 17–25.347.Roten L.T., Johnson M.P., Forsmo S. Fitzpatrick E, Dyer TD, BrenneckeSP, Blangero J, Moses EK, Austgulen R. Association between the candidatesusceptibility gene ACVR2A on chromosome 2q22 and pre-eclampsia in a largeNorwegian population-based study (the HUNT study) // Eur. J. Hum. Genet.
–2009. – V. 17, № 2. – P. 250–257.348.Roten L.T., Fenstad M.H., Forsmo S., Johnson M.P., Moses E.K.,Austgulen R., Skorpen F. A low COMT activity haplotype is associated withrecurrent preeclampsia in a Norwegian population cohort (HUNT2) // Mol. Hum.Reprod. – 2011. – V. 17, № 7. – P. 439–446.349.Sachse C., Brockmoller J., Bauer S., Roots I. Cytochrome P450 2D6variants in a Caucasian population: allele frequencies and phenotypicconsequences // Am. J. Hum.
Genet. – 1997. – V. 60. – P. 284–295.350.Safar M.E., Lajemi M., Rudnichi A., Asmar R., Benetos A. Angiotensin-converting enzyme D/I gene polymorphism and age-related changes in pulsepressure in subjects with hypertension // Arterioscler. Thromb. Vasc. Biol. – 2004.– V. 24(4). – P. 782–786.351.Salah A., Khan M., Esmail N., Habibullah S., Al Lahham Y. Geneticpolymorphism of S447X lipoprotein lipase (LPL) and the susceptibility tohypertension // J.
Crit. Care. – 2009. – V. 24, № 3. – P. 11–14.352.Sambrook J., Fritsch E.F., Maniatis T. Molecular cloning: A LaboratoryManual - NY.: Coldspring Harbour Laboratory Press. - 1989. — 1626 p.404405353.Samochatova E.V., Chupova N.V., Rudneva A., Makarova O., NasedkinaT.V., Fedorova O.E., Glotov A.S., Kozhekbaeva Zh., Maiorova O.A.,Roumyantsev A.G., Krynetski E.Y., Krynetskaia N.F., Evans W.E., Ribeiro R.C.TPMT genetic variations in populations of the Russian Federation // Pediatr. BloodCancer. – 2009. – V.
52(2). – P. 203–208.354.Santoro N., Perrone L., Cirillo G., Raimondo P., Amato A., Coppola F.,Santarpia M., D'Aniello A., Miraglia Del Giudice E. Weight loss in obese childrencarrying the proopiomelanocortin R236G variant // J. Endocrinol. Invest. – 2006. –V. 29(3). – P. 226–230.355.Schnabel R.B., Baccarelli A., Lin H., Ellinor P.T., Benjamin E.J. Nextsteps in cardiovascular disease genomic research--sequencing, epigenetics, andtranscriptomics // Clin.
Chem. – 2012. – V. 58, №1. – P. 113–126.356.Schneider S., Freerksen N., Röhrig S., Hoeft B., Maul H. Gestationaldiabetes and preeclampsia--similar risk factor profiles? // Early Hum. Dev. – 2012.– V. 88, № 3. – P. 179–184.357.Searle N.R., Sahab P. Endothelial vasomotor regulation in health anddisease // Can. J. Anaesth. – 1992. – V.
3921. – P. 838–857.358.Sefri H., Benrahma H., Charoute H., Lakbakbi E., Yaagoubi F., Rouba H.,Lyoussi B., Nourlil J., Abidi O., Barakat A. TNF A -308G>A polymorphism inMoroccan patients with type 2 diabetes mellitus: a case-control study and metaanalysis // Mol. Biol. Rep. – 2014. – V. 41(9). – P. 5805–5811.359.Serrano N.C., Casas J.P., Díaz L.A., Páez C., Mesa C.M., Cifuentes R.,Monterrosa A., Bautista A., Hawe E., Hingorani A.D., Vallance P., LópezJaramillo P. Endothelial NO synthase genotype and risk of preeclampsia: amulticenter case-control study // Hypertension. – 2004. – V.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
